| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $1.32 ▲ +4.76% | Yesterday | $1.27 ▼ -0.79% | Tomorrow's Telomir Pharmaceuticals Inc. Common Stock (TELO) setup is anchored to $1.26 and targets $1.32 (+4.76%). The near-term read is upside; watch $1.30 / $1.22 because daily realized volatility is about 3.15%. |
Tomorrow's Telomir Pharmaceuticals Inc. Common Stock (TELO) setup is anchored to $1.26 and targets $1.32 (+4.76%). The near-term read is upside; watch $1.30 / $1.22 because daily realized volatility is about 3.15%. | ||||
| Week | $1.39 ▲ +10.32% | Last Week | $1.30 ▼ -3.08% | The 7-day Telomir Pharmaceuticals Inc. Common Stock model moves from $1.30 to $1.39 (+10.32%). It gives upside momentum context for this stock, so breaks around $1.30 / $1.22 matter more than a single tick. |
The 7-day Telomir Pharmaceuticals Inc. Common Stock model moves from $1.30 to $1.39 (+10.32%). It gives upside momentum context for this stock, so breaks around $1.30 / $1.22 matter more than a single tick. | ||||
| Month | $1.47 ▲ +16.67% | Last Month | $1.45 ▼ -13.10% | The 1-month Telomir Pharmaceuticals Inc. Common Stock target is $1.47 (+16.67%), compared with the live reference near $1.26. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Telomir Pharmaceuticals Inc. Common Stock target is $1.47 (+16.67%), compared with the live reference near $1.26. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $1.57 ▲ +24.60% | Last Year | $2.50 ▼ -49.60% | The 1-year Telomir Pharmaceuticals Inc. Common Stock scenario points to $1.57 (+24.60%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Telomir Pharmaceuticals Inc. Common Stock scenario points to $1.57 (+24.60%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $1.82 ▲ +44.44% | 5 Years Ago | $5.00 ▼ -74.80% | The 5-year Telomir Pharmaceuticals Inc. Common Stock view is $1.82 (+44.44%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Telomir Pharmaceuticals Inc. Common Stock view is $1.82 (+44.44%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 9.4 | Bearish |
| MACD | 0.11 | Bullish |
| SMA 50 | $1.34 | Mid |
| SMA 200 | $1.88 | Mid |
| EMA 20 | $2.02 | Mid |
| Opening Price | $1.27 | Start Date | 2024-02-09 |
| Day Range | $1.23 – $1.30 | Market Cap | $47.79M |
| Monthly Range | $1.22 – $1.48 | 24h Volume | n/a |
| 90D Range | $1.08 – $1.48 | Circulating | n/a |
| 52W Range | $1.08 – $6.52 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.